Clinical Trial Update: Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for intravitreal bevacizumab in nonproliferative diabetic retinopathy across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Non-proliferative Diabetic Retinopathy | Phase 2, Phase 3 | Status: UNKNOWN